Both compounds are selective and do not overly stimulate other hormone pathways, making them a favorite for long-term use and first-time peptide users
Tuersun A., Hou G., and Cheng G., Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated MetaAnalysis of Randomized Controlled Trials, Clinical Therapeutics 46, no
Scientific research specific to the eating plan is in short supply, says Patton
Every patient is unique, so our team will assess your health history, weight loss goals, and overall suitability for these medications during your consultation
TRIUMPH-2 (Obesity with Obstructive Sleep Apnea) TRIUMPH-2 evaluates retatrutide in adults with obesity and obstructive sleep apnea (OSA), a key comorbidity subset within the broader obesity program
Diabetes Care 1 January 2024